MedPath

The effect of rivaroxaban for hemodynamics in left atrium and thrombotic / thrombolytic biomarkers

Not Applicable
Conditions
non-valvular atrial fibrillation
Registration Number
JPRN-UMIN000020806
Lead Sponsor
Jichi Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

paroxysmal atrial fibrillation obvious thrombus in LA or LAA cardiac tumor including myxoma contraindication of rivaroxaban creatinine clearance under 30ml/min unstable blood pressure control unstable control of blood sugar heart failure functional class NYHA 3 or 4 other unsuitable situation for this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath